FR2619567B1 - Cristaux de serum-albumine humaine et procede pour leur preparation - Google Patents

Cristaux de serum-albumine humaine et procede pour leur preparation

Info

Publication number
FR2619567B1
FR2619567B1 FR8811096A FR8811096A FR2619567B1 FR 2619567 B1 FR2619567 B1 FR 2619567B1 FR 8811096 A FR8811096 A FR 8811096A FR 8811096 A FR8811096 A FR 8811096A FR 2619567 B1 FR2619567 B1 FR 2619567B1
Authority
FR
France
Prior art keywords
preparation
human serum
albumin crystals
albumin
crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8811096A
Other languages
English (en)
Other versions
FR2619567A1 (fr
Inventor
Carter Daniel Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Aeronautics and Space Administration NASA
Original Assignee
National Aeronautics and Space Administration NASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Aeronautics and Space Administration NASA filed Critical National Aeronautics and Space Administration NASA
Publication of FR2619567A1 publication Critical patent/FR2619567A1/fr
Application granted granted Critical
Publication of FR2619567B1 publication Critical patent/FR2619567B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/30—Self-sustaining carbon mass or layer with impregnant or other layer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31536—Including interfacial reaction product of adjacent layers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31725—Of polyamide
    • Y10T428/31768—Natural source-type polyamide [e.g., casein, gelatin, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8811096A 1987-08-20 1988-08-22 Cristaux de serum-albumine humaine et procede pour leur preparation Expired - Fee Related FR2619567B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/087,281 US4833233A (en) 1987-08-20 1987-08-20 Human serum albumin crystals and method of preparation

Publications (2)

Publication Number Publication Date
FR2619567A1 FR2619567A1 (fr) 1989-02-24
FR2619567B1 true FR2619567B1 (fr) 1995-02-17

Family

ID=22204235

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8811096A Expired - Fee Related FR2619567B1 (fr) 1987-08-20 1988-08-22 Cristaux de serum-albumine humaine et procede pour leur preparation

Country Status (7)

Country Link
US (1) US4833233A (fr)
EP (1) EP0357857B1 (fr)
JP (1) JPH064677B2 (fr)
AU (1) AU604958B2 (fr)
CA (1) CA1336530C (fr)
DE (1) DE3878239T2 (fr)
FR (1) FR2619567B1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927345A1 (de) * 1989-08-18 1991-02-21 Biotechnolog Forschung Gmbh Verfahren zur strukturbestimmung von peptiden
ATE195553T1 (de) 1992-06-09 2000-09-15 Chiron Corp Kristallisierung von m-csf
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5554522A (en) * 1994-04-28 1996-09-10 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Dihydrodipicolinate reductase crystals and three dimensional structure
US5585466A (en) * 1994-12-06 1996-12-17 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Crystals of serum albumin for use in genetic engineering and rational drug design
US5641681A (en) * 1995-04-17 1997-06-24 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Device and method for screening crystallization conditions in solution crystal growth
US5978740A (en) * 1995-08-09 1999-11-02 Vertex Pharmaceuticals Incorporated Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them
US6128582A (en) * 1996-04-30 2000-10-03 Vertex Pharmaceuticals Incorporated Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
US6153579A (en) 1996-09-12 2000-11-28 Vertex Pharmaceuticals, Incorporated Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
US5872011A (en) * 1997-06-13 1999-02-16 The Rockefeller University Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof
US6020162A (en) * 1997-06-13 2000-02-01 The Rockefeller University Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof
US6183121B1 (en) 1997-08-14 2001-02-06 Vertex Pharmaceuticals Inc. Hepatitis C virus helicase crystals and coordinates that define helicase binding pockets
US7383135B1 (en) 1998-05-04 2008-06-03 Vertex Pharmaceuticals Incorporated Methods of designing inhibitors for JNK kinases
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US20020042046A1 (en) * 1999-02-25 2002-04-11 Vertex Pharmaceuticals, Incorporated Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
US7244396B2 (en) * 1999-04-06 2007-07-17 Uab Research Foundation Method for preparation of microarrays for screening of crystal growth conditions
US7214540B2 (en) * 1999-04-06 2007-05-08 Uab Research Foundation Method for screening crystallization conditions in solution crystal growth
EP1701159A3 (fr) * 1999-04-06 2007-07-25 University of Alabama Procede de criblage de conditions de croissance cristalline de proteins en solution.
EP1181548B1 (fr) * 1999-04-06 2007-03-21 The University of Alabama at Birmingham Research Foundation Procede de criblage des conditions de cristallisation dans des solutions de tirage de cristal
US20030022383A1 (en) * 1999-04-06 2003-01-30 Uab Research Foundation Method for screening crystallization conditions in solution crystal growth
US7247490B2 (en) * 1999-04-06 2007-07-24 Uab Research Foundation Method for screening crystallization conditions in solution crystal growth
US7250305B2 (en) * 2001-07-30 2007-07-31 Uab Research Foundation Use of dye to distinguish salt and protein crystals under microcrystallization conditions
US6630006B2 (en) 1999-06-18 2003-10-07 The Regents Of The University Of California Method for screening microcrystallizations for crystal formation
US6296673B1 (en) 1999-06-18 2001-10-02 The Regents Of The University Of California Methods and apparatus for performing array microcrystallizations
BR0207422A (pt) * 2001-02-09 2005-04-19 Genentech Inc Cristal formado por igf-1, composição, método de tratamento de mamìferos que sofrem de disfunção de um agonista, método de cristalização de igf-1, igf-1 cristalino, métodos de identificação de agonistas indiretos de igf-1, complexo co-cristalino, método de determinação de estrutura tridimensional de igf-1, meio de armazenagem de dados legìvel por máquina, cristal de igf-1, método de uso de estrutura tridimensional de igf-1, método de identificação de agonistas ou antagonistas de igf-1, método de projeto de composto, método de identificação de peptidomimético, método de determinação de pelo menos uma parte de estrutura tridimensional de um complexo molecular, método de avaliação da capacidade de uma entidade quìmica de associar-se com igf-1, entidade quìmica, derivado de átomo pesado, método de avaliação experimental ou computacional de uma entidade quìmica e uso de uma composição
WO2002074246A2 (fr) * 2001-03-20 2002-09-26 New Century Pharmaceuticals, Inc. Procede et compositions permettant d'optimiser la stabilite du sang et des tissus conferee par la camptothecine et par d'autres composes therapeutiques liant l'albumine
US7670429B2 (en) * 2001-04-05 2010-03-02 The California Institute Of Technology High throughput screening of crystallization of materials
EP1401857A4 (fr) * 2001-06-13 2004-07-21 Taurus Hsa Llc Purification de la serum-albumine humaine
KR20030022917A (ko) * 2001-09-11 2003-03-19 크리스탈지노믹스(주) 소테이즈의 결정화 방법
US20040137518A1 (en) * 2002-01-31 2004-07-15 Lambert Millard Hurst CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME
US20070026528A1 (en) * 2002-05-30 2007-02-01 Delucas Lawrence J Method for screening crystallization conditions in solution crystal growth
WO2004005898A1 (fr) * 2002-07-10 2004-01-15 Uab Research Foundation Procede permettant de faire la distinction entre cristaux biomoleculaires et cristaux non biomoleculaires
JP3567988B2 (ja) * 2002-07-11 2004-09-22 独立行政法人理化学研究所 生体高分子の結晶化条件探査方法及び探査装置
US20040102380A1 (en) * 2002-11-18 2004-05-27 Fulton Scott P. Method for continuous, automated blending of solutions from acids and bases
US7087719B2 (en) 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin
EP1627323A4 (fr) * 2003-05-06 2008-04-09 New Century Pharmaceuticals Sites de fixation sur l'albumine pour l'evaluation d'interactions medicamenteuses ou la mise au point de medicaments en fonction de leur proprietes de liaison a l'albumine
CA2585115A1 (fr) * 2003-11-03 2005-05-12 New Century Pharmaceuticals, Inc. Sites de liaison a l'albumine permettant d'evaluer des interactions medicamenteuses et procedes d'evaluation ou de conception de medicaments fondes sur les proprietes de liaison a l'albumine de ces derniers
US7507552B1 (en) 2004-04-16 2009-03-24 Takeda San Diego, Inc. Crystallization of histone deacetylase 2
US8176808B2 (en) * 2007-09-13 2012-05-15 Foster-Miller, Inc. Robot arm assembly
WO2013036829A1 (fr) 2011-09-09 2013-03-14 Genentech, Inc Traitement de maladies inflammatoires induites par les th17

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (fr) * 1962-01-03
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
US4197238A (en) * 1977-04-12 1980-04-08 The Green Cross Corporation Method of preparation of human albumin using polyethylene glycol
US4164496A (en) * 1978-08-23 1979-08-14 American National Red Cross Preparation of albumin using PEG and EDTA
US4489133A (en) * 1982-11-16 1984-12-18 The Board Of Trustees Of The Leland Stanford Jr. University Two-dimensional crystallization technique
US4668584A (en) * 1985-12-23 1987-05-26 General Electric Company Method for forming 2-D crystals of proteins and macromolecules

Also Published As

Publication number Publication date
CA1336530C (fr) 1995-08-01
EP0357857A1 (fr) 1990-03-14
DE3878239T2 (de) 1993-09-09
AU2109888A (en) 1989-02-23
AU604958B2 (en) 1991-01-03
DE3878239D1 (de) 1993-03-18
JPH01238599A (ja) 1989-09-22
FR2619567A1 (fr) 1989-02-24
US4833233A (en) 1989-05-23
JPH064677B2 (ja) 1994-01-19
EP0357857B1 (fr) 1993-02-03

Similar Documents

Publication Publication Date Title
FR2619567B1 (fr) Cristaux de serum-albumine humaine et procede pour leur preparation
FR2618337B1 (fr) Pansement chirurgical et procede pour le fabriquer
FR2616428B1 (fr) Grain poreux d'ergol et son procede de preparation
OA08694A (fr) Acides 3-pyrrolidinylthio-1-azabicyclo [3.2.0] -hept-2-ène-2-carboxyliques et procédés pour leur préparation.
FR2646083B1 (fr) Dispositif et procede pour le traitement de dechets medicaux speciaux
PT86772A (pt) Process for preparing human interleukin-3 and muteins thereof
FR2611208B1 (fr) Procede pour la preparation de polyorganosilazanes et de materiaux ceramiques en derivant
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
MA21413A1 (fr) Nouveau procede de preparation d'alcoxy-guanine
MC1499A1 (fr) Interferon immun humain homogene et procede pour sa preparation
FR2580469B1 (fr) Procede et dispositif pour la preparation de croissants
FR2612373B1 (fr) Compositions dietetiques et procede pour leur preparation
FR2618351B1 (fr) Emulsions gelifiees transparentes et leur procede d'obtention
MC1554A1 (fr) Ethers-oxydes de l'antibiotique x-14868a et procede pour leur preparation
GB8822205D0 (en) Method of examining coin with respect to identity thereof & apparatus for examining coin with respect to identity thereof
FR2640632B1 (fr) Alliages polycondensats thermoplastiques-silicones et leur procede de preparation
FR2565105B1 (fr) Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer
FR2609624B1 (fr) Procede et seringue pour prelevement cytologique
FR2608378B1 (fr) Miels aromatises et leur procede de preparation
FR2559771B1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
FR2640140B1 (fr) Compositions pour le traitement de phlebectasies et leur procede de preparation
FR2624861B1 (fr) Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
MC1740A1 (fr) Glyocides et procede pour leur preparation
FR2599037B1 (fr) Dihydrogeno-1,3 disilazanes fonctionnels et procede pour leur preparation
FR2601033B1 (fr) Variants de l'alpha-antitryspine humaine glycosylee et procede pour la preparation

Legal Events

Date Code Title Description
ST Notification of lapse